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Abstract
Introduction: The EQ-5D is a widely-used, standardised, quality of life measure producing health profiles, indices and states.
The aims of this study were to assess the role of various factors in how people with Multiple Sclerosis rate their quality of
life, based on responses to the EQ-5D received via the web portal of the UK MS Register.
Methods: The 4516 responses to the EQ-5D (between May 2011 and April 2012) were collated with basic demographic and
descriptive MS data and the resulting dataset was analysed in SPSS (v.20).
Results: The mean health state for people with MS was 59.73 (SD 22.4, median 61), compared to the UK population mean of
82.48 (which is approximately 1SD above the cohort mean). The characteristics of respondents with high health states (at or
above +1SD) were: better health profiles (most predictive dimension: Usual Activities), higher health indices, younger age,
shorter durations of MS, female gender, relapsing-remitting MS, higher educational attainment and being in paid
employment (all p-values,0.001). Conversely, the characteristics of respondents with low health states (at or below -1SD)
were: poorer health profiles (most predictive dimension: Mobility), lower health indices, older age, longer durations of MS,
male gender, progressive MS, lower educational attainment and having an employment status of sick/disabled (p= 0.0014
for age, all other p-values,0.001). Particular living arrangements were not associated with either the high or low health
status groups.
Conclusions: This large-scale study has enabled in-depth analyses on how people with MS rate their quality of life, and it
provides new knowledge on the various factors that contribute to their self-assessed health status. These findings
demonstrate the impact of MS on quality of life, and they can be used to inform care provision and further research, to work
towards enhancing the quality of life of people with MS.
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Introduction
The EQ-5D is a widely used, standardised, health-related
quality of life measure developed by the EuroQol Group to
provide a simple generic assessment for use in clinical and
economic studies [1,2]. It consists of the EQ-5D descriptive system
and the EQ visual analogue scale (EQ-VAS). The descriptive
system has five dimensions: Mobility, Self-care, Usual activities,
Pain/discomfort and Anxiety/depression. Each dimension has 3
levels: no problems, some problems or severe problems, and this
provides a health profile of the respondents. By taking the five digit
responses, the health profiles can be translated into weighted
health indices, which in the UK is usually done using the Time
Trade Off (TTO) procedure [1,3]. The EQ-VAS allows respon-
dents to indicate their self-assessed health state on a visual
analogue scale with 0 being their worst imagined health state, and
100 the highest. We will refer to these values as health profiles,
health indices and health states/status in this study on quality of
life in people with Multiple Sclerosis (MS) via the UK MS
Register.
MS is a chronic, inflammatory, auto-immune condition
characterised by demyelination of nerve fibres resulting in a range
of symptoms and disabilities. There are estimated to be between
85,000 and 100,000 people with MS in the UK, but there is an
acknowledged lack of epidemiological information about this
debilitating condition [4]. The UK MS Register has been
developed to address the need for a greater knowledge-base about
MS. It has been designed to capture and bring together datasets
from three main sources: clinical information systems operating in
NHS Neurology clinics, routinely-collected administrative data,
and directly from people with MS via a purpose built web portal
operating as a questionnaire delivery platform [5]. The web portal
was launched in May 2011 and, by April 2012, 8736 people with
MS had enrolled, with further data collection underway as a
continual process. The acquisition of data from Neurology clinics
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and administrative sources is progressing, subject to participant
consent and data availability. The data model of the UK MS
Register is innovative in its design and provides new opportunities
for studying MS via linked data. The Register is based on the
proven technologies and robust Information Governance arrange-
ments in place in the Secure Anonymised Information Linkage
(SAIL) system developed by the Health Information Research
Unit (HIRU) [6,7].
The web portal hosts a variety of validated questionnaires to
capture information on the health and well-being of people with
MS. These include the Hospital Anxiety and Depression Scale
(HADS) [8], and the MS Disease Impact Scale-29 (MSIS-29) [9],
and we have previously shown how the responses to these scales
can be used to address research questions about the experience of
living with MS [10,11]. The EQ-5D is used internationally in
general populations and condition-specific cohorts [12,13] and
because of its importance and wide usage, we included it as a
questionnaire on the web portal of the UK Multiple Sclerosis
Register.
Research Aim
The aim of this study was to use the responses to the EQ-5D
gained via the web portal to assess the role of various factors in
how people with MS rate their quality of life. This is the largest
known study of its kind in people with MS, and the first to use the
EQ-5D responses from the UK MS Register. We therefore set out
to describe the cohort for comparison with other studies and for
those who may wish to use the Register data in the future. We
compared the health status of our respondents with the general
UK population and then examined the factors that characterise
those with high self-rated health states and those with low self-
rated health states. From previous studies, including those using
the web portal data [10,11], it was be expected that people with
MS with high health states would differ in at least some of their
characteristics compared to people with MS with low health states.
For example, people with a progressive type of MS and longer
durations of the condition would be likely to report poorer quality
of life than those with relapsing-remitting MS and shorter
durations. However, the influences of various other factors, such
as which (if any) of the EQ-5D dimensions are most predictive of
either a high of low self-rated health status, were not known.
Methods
Research Ethics and Governance
The UK MS Register study was peer-reviewed via the MS
Society and has obtained ethical approval from the South West –
Central Bristol Research Ethics Committee (11/SW/0160) as a
research database [14]. Under this ethical approval, data collected
via the web portal, the Neurology clinics and routine administra-
tive sources can be anonymously linked using the SAIL
methodologies provided that agreement to the portal terms of
service (via the portal) and written informed participant consent (at
the clinics) have been obtained. The working UK MS Register
contains only anonymous data but facilities are in place to re-
contact participants to take part in further research [15]. In future,
the Register data will be made accessible for analysis by
researchers external to the team, subject to regulatory and
governance requirements. The final operating model for these
arrangements is yet to be determined, but we are able at
accommodate researcher requests to view the data in the interim,
subject to any necessary amendments to regulatory and gover-
nance approvals and a non-disclosure agreement.
Data Collection and Analysis
Adults in the UK who have MS have been able to enrol on the
UK MS Register via the web portal since its launch in May 2011.
From then until April 2012, 4516 people completed the EQ-5D
questionnaire. These responses were collated with basic demo-
graphic, descriptive MS data and information on employment
status, educational attainment and living arrangements from the
questionnaire entitled ‘You, your MS and lifestyle’ [5] and the
resulting dataset was analysed in SPSS (v.20). The health profiles
were treated as categorical data, the health indices (calculated
using the TTO method) [3] and health states were treated as
continuous. All the continuous variables were assessed for
normality using the Kolmogorov-Smirnov test and all were found
to deviate significantly from the normal distribution (all p values
0.001). Because of this, non-parametric inferential tests were used:
Spearman’s rank correlation coefficient to measure relationships
between variables, the Mann-Whitney U test was used to assess
differences between two independent samples, and the Kruskal-
Wallis one-way analysis of variance was used to compare more
than two independent samples. Logistic regression was used to
predict the outcome of categorical variables, and the chi squared
test was used to assess goodness of fit between categorical
variables. A Bonferroni correction was used, where relevant, to
avoid over-reporting significance where multiple tests were
conducted. This was calculated as the significance level divided
by the number of tests undertaken. In order to assess the
characteristics associated with high health states the cohort was
divided into two categories: those with a health status at or above
1SD above the mean (denoted as High-VAS), and those with a
health status below this value. A similar method was used to study
low health states, with the Low-VAS group denoted as having a
health status at or below 1SD below the mean for the cohort.
Workforce age is defined as ,=59 for women and ,=64 for
men [16].
Results
Description of Respondents
The sample was comprised of 71.1% women and 28.9% men,
representing a ratio of 2.46 women: 1 man (N=4516). The
distribution of types of MS were: 14.8% primary progressive MS
(PPMS), 62.1% relapsing-remitting MS (RRMS), 8.1% secondary
progressive MS (SPMS) and 14.9% did not know their type of MS
(DKMS) (N=4422). The mean age of the respondents was 50.7
years (SE 0.17, SD 11.2) with a median of 51 years (IQR 16). The
mean time since diagnosis (by a Neurologist) was 10.9 years (SE
0.15, SD 8.9) with a median of 9 years (IQR 12). The mean health
index was 0.567 (SE 0.003, SD 0.207) with a median of 0.596
(IQR 0.242). The mean health state was 59.73 (SE 0.33, SD 22.42)
with a median of 61 (IQR 32). By comparison, the mean UK
population health index and health state have been measured as
0.860 and 82.48 respectively [3]. The health indices and health
states were higher for women than for men (Mann-Whitney
p,0.001, p,0.001), and were highest in people with RRMS
compared to other types of MS (Kruskal-Wallis p-,0.001,
p,0.001). From previous studies, it is known that the distribution
of types of MS differs between the genders [10,17], but when
gender was controlled for, health indices and health states were
also highest in RRMS in both men and women (Kruskal-Wallis all
p-values,0.001). Further details are given in Table 1, including
values by gender and type of MS.
Health profiles were examined to assess the proportions of
people with MS at each level on the five dimensions, and the
percentages of people reporting at least some problems can be seen
How People with MS Rate Their Quality of Life
PLOS ONE | www.plosone.org 2 June 2013 | Volume 8 | Issue 6 | e65640
in Figure 1. Over four-fifths of the respondents (82.5%) reported
experiencing problems in carrying out their Usual activities, and
over three-quarters had problems Pain/discomfort (76.3%) and
with Mobility (75.9%). When gender was included as a factor, it
was found that men experienced problems more frequently than
women in Mobility, Self-care and Usual Activities (all chi squared
p-values,0.001), but there was no significant difference between
the health profiles of men and women in Pain/discomfort and
Anxiety/depression. Health profiles were assessed by respondent
age in bands, and were found to differ on all 5 dimensions across
the age ranges (chi-squared, all p-values,0.001) with greater
proportions of people with problems in Mobility, Self-care and
Usual activities as age increased. A similar pattern was observed in
the general UK population, as would be expected, but problems
were more frequent in people with MS across the age bands [12].
However, the profile pattern was more variable within the
dimension of Pain/discomfort, and within Anxiety/depression
the frequencies of people experiencing problems showed some
decrease with age. Analysis of the health profiles by type of MS
showed that problems were more frequent in the progressive types
of MS than in RRMS for the dimensions of Mobility, Self-care,
Usual Activities and Pain/discomfort (chi-squared, all p-val-
ues,0.001). There were differences in the health profiles of
Anxiety/depression by type of MS but the pattern was more
variable (p=0.03). Health profiles by age band, gender and type of
MS are shown in Table 2.
Relationships between Continuous Variables
Since health indices are calculated values based on responses on
the 5 dimensions, and health states are based on a respondent’s
general perception of their quality of life, the relationship between
health indices and health states was assessed using Spearman’s
rank correlation. A moderately strong positive relationship was
found (rho=0.61, p,0.001). Having observed that the frequencies
of problems varied with age, the relationships between age,
duration of MS, health index and health state were measured.
Weak negative relationships were found: rho=20.16 for age
against health index (p,0.001) and rho=20.11 for age against
health state. (p,0.001). Similarly, duration of MS against health
index and against health state yielded values of rho=20.20 and
rho=20.14, respectively (p,0.001, p,0.001).
Lifestyle Factors
It has been observed that quality of life (health index and health
state) varies with lifestyle factors such as educational attainment,
employment status and living arrangements [3 UK norms] and
these factors were examined in our cohort of people with MS.
Among our respondents the highest educational levels attained
were: 25.0% secondary school, 31.8% higher education, and
43.2% occupational or other qualifications. Of these, the highest
health indices and health states were among those with higher
education (Kruskal-Wallis p,0.001, p,0.001), as observed in the
general UK population [3 UK norms]. However, within types of
MS, there was no significant difference across the educational
levels in the health indices of people with SPMS, or in the health
states of people with either PPMS or SPMS. For people of
workforce age, 47.5% were in gainful employment and this group
reported higher health indices and health states than those who
were not working (Mann-Whitney p,0.001, p,0.001). This was
also the case within each type of MS (all p-values,0.001). Within
the potential workforce, 31.3% reported their employment status
as sick/disabled and, as would be expected, this group reported
lower health indices and health states than those who were not
sick/disabled (Mann-Whitney p,0.001, p,0.001); the same was
observed for each type of MS (all p-values,0.001). Approximately
three quarters (75.6%) of our respondents were living as part of a
couple and the remainder were not, and their health indices and
health states were compared based on this criterion. There was no
significant difference in the health indices, but people living as part
of a couple reported a higher health state (Mann-Whitney
p=0.04). However, within types of MS, the difference in health
states was only significant for people with DKMS (p,0.001). The
living arrangements of the respondents were also (separately)
categorised on the basis of whether they lived with dependent
children (41.9%), with non-dependents (52.3%) or alone (5.8%).
People living with dependents had the highest health indices
(Kruskal-Wallis p,0.001) and although they had the highest
health states, the differences were not significant. These analyses
led to assessing what general and MS-related factors are associated
with high and low health states for the cohort.
Table 1. Timelines, health indices and health states of the
cohort.
Categories N Mean SD SE MedianIQR Range
Age (yrs):
All 4506 50.7 11.2 0.17 51.0 16 20 to 87
Men 1301 52.8 11.4 0.31 53.0 16 23 to 87
Women 3197 49.9 11.4 0.20 50.0 16 20 to 84
Time since diagnosis (yrs):
All 3575 10.9 8.8 0.15 9.0 12 0 to 63
Men 1023 11.3 8.9 0.28 10.0 13 0 to 48
Women 2535 10.8 8.9 0.18 9.0 12 0 to 63
Health index (decimal)
All 4516 0.567 0.207 0.003 0.596 0.242 0.014 to
1.00
Male 1301 0.542 0.209 0.006 0.566 0.299 0.014 to
1.00
Female 3198 0.577 0.206 0.004 0.596 0.195 0.014 to
1.00
PPMS 654 0.496 0.183 0.007 0.511 0.295 0.014 to
1.00
RRMS 2747 0.595 0.209 0.007 0.596 0.227 0.075 to
1.00
SPMS 360 0.466 0.189 0.010 0.503 0.291 0.014 to
1.00
DKMS 661 0.577 0.198 0.008 0.596 0.219 0.014 to
1.00
Health status (0 to 100)
All 4516 59.73 22.4 0.33 61.0 32 0 to 100
Men 1301 56.67 22.8 0.63 60.0 34 0 to 100
Women 3198 61.01 22.1 0.39 64.0 30 0 to 100
PPMS 654 54.84 22.2 0.87 59.0 30 0 to 100
RRMS 2747 62.02 22.9 0.42 64.0 30 0 to 100
SPMS 360 51.10 22.1 1.16 51.0 30 0 to 100
DKMS 661 59.89 22.9 0.89 60.0 35 0 to 100
Descriptions of the variables are shown. Slight differences in totals within
categories compared to all are due to the small percentages (,2%) of
participants for whom either age, gender or type of MS was missing.
doi:10.1371/journal.pone.0065640.t001
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Factors Associated with High and Low Health States
It had been observed that the UK general population mean
health state (of 82.48) [3] was approximately 1SD above the
cohort mean (of 59.73, SD 22.4). This was used as the basis for
characterising a high health state group (High-VAS, having health
states at least 1SD above the mean, N=731) and a low health state
group (Low-VAS, having health states at least 1SD below the
mean, N=695). Beginning with an analysis of factors associated
with high health states, the general and MS-specific characteristics
of the High-VAS group were compared with those with a health
state below this value. It was found that the High-VAS group was
characterised by better health profiles on all 5 dimensions (all chi
squared p,0.001), higher health indices (Mann-Whitney
p,0.001), younger age (Mann-Whitney p,0.001), shorter dura-
tions of MS (Mann-Whitney p,0.001), female gender (chi squared
p,0.001), RRMS (chi squared p,0.001), higher educational
attainment (chi squared p,0.001), and being in paid employment
(chi squared p,0.001). A similar analysis comparing the Low-VAS
group with the remainder of the cohort showed that the factors
associated with the Low-VAS group were: poorer health profiles
on all 5 dimensions (all chi squared p,0.001), lower health indices
(Mann-Whitney p,0.001), older age (Mann-Whitney p=0.0014),
longer durations of MS (Mann-Whitney p,0.001), male gender
(chi squared p,0.001), a progressive type of MS (chi squared
p,0.001), lower educational attainment (chi squared p,0.001)
and having an employment status of sick/disabled (chi squared
p,0.001)). Particular living arrangements (as categorised earlier)
were not associated with either the High-VAS or Low-VAS
groups. Significance (at the 95% level) was retained for all
variables when a Bonferroni correction was applied (based a
required p value of 0.0042). Logistic regression was used to
estimate which of the health profile dimensions were most likely to
predict a High-VAS or Low-VAS health state. Odds ratios of
being in the High-VAS group were calculated relative to having
severe problems (profile = 3). Better health profiles gave increased
odds of being in the High-VAS group on all the dimensions with
the most predictive being Usual Activities (Odds ratios: 13.33 [CI
10.98, 15.87] for some problems compared to severe problems,
and 41.67 [CI 25.64, 66.6] for no problems compared to severe
problems). Odds ratios of being in the Low-VAS group were
calculated relative to having no problems (profile = 1). Poorer
health profiles gave increased odds of being in the Low-VAS group
on all the dimensions with the most predictive being Mobility
(Odds ratios: 5.41 [CI 3.9, 7.46] for some problems compared to
no problems, and 43.48 [CI 27.03, 71.43] for severe problems
compared to no problems). All the odds ratios and confidence
intervals are compared in Table 3 (all p-values,0.001).
Discussion
Main Findings
This large-scale study has used over 4500 responses to the EQ-
5D to examine how people with MS rate their health-related
quality of life by assessing the health profiles, health indices and
health states of the cohort. Analysis of the health profiles revealed
a high prevalence of problems in all 5 domains, with less than 25%
of people reporting no problems with Mobility and with Pain/
discomfort and less than 20% reporting no problems in carrying
out their Usual Activities. As might be expected, there were
differences in the patterns of problems between the genders and
between people with different types of MS, with greater
proportions of men and people with a progressive type of MS
usually experiencing more problems. The frequencies of problems
increased with age, as observed in the general UK population [3],
but this was not the case with Anxiety/depression, where the
converse was observed to some extent. This sort of pattern was
also noted in a previous study where the HADS scores (particularly
for anxiety) of people with MS decreased with age [10].
Considering that the health indices are calculated from the health
profile scores, it is worth bearing in mind that a person’s health
index measured repeatedly over the disease course may be
comprised of health profiles varying in either direction, and it is
possible that this effect could partly obscure health deteriorations
Figure 1. Health profiles of the cohort of people with MS. The frequencies of people with MS reporting no problems (level 1), some problems
(level 2) and severe problems (level 3) on each of the 5 dimensions are indicated to show the health profiles of the cohort.
doi:10.1371/journal.pone.0065640.g001
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in some dimensions. The health indices of the cohort were notably
lower than those of the general UK population. In fact, a
comparative study of well over a hundred health conditions found
that the health indices of people with MS are among the very
lowest [13].
There was a moderately strong positive relationship between
health indices and health states. Unlike health indices, health states
are based on the respondent’s overall feeling about their quality of
life, and so are not based directly on clinical symptoms. In a study
focussing on asthma, it was found that clinical status does not
always predict self-rated health state [18]. This may be because
people with a chronic condition develop coping strategies to
realign their expectations and experience and so they may rate
their quality of life higher than might be expected from their
clinical status [19]. However, that should not be a reason to
underestimate the impact of their condition on their well-being,
but rather it shows how people are adapting to their circumstances
[20].
In common with the general UK population, it was found that
higher educational attainment was associated with higher health
states in the cohort as a whole. However, this relationship did not
hold for people with PPMS or SPMS, for whom there was no
significant difference in health states by educational attainment
and this may be due to the impact of their condition. Generally,
there were no significant differences in the health states of people
according to their living arrangements. As would be expected,
people in paid employment reported higher health states than
those who were not working, and a recent cross-sectional UK
study has highlighted the association between detachment from
the labour market and poor self-rated health [21]. The ability to
remain active and to be able to take part in the workforce is an
important factor that we highlighted in a previous study [11].
People with high health states (High-VAS) had different
characteristics to the remainder of the cohort, and, of course,
some of these factors are related; for example younger age and
shorter duration of MS, being female and having RRMS. The
people with low health states (Low-VAS) also differed from the
remainder of the cohort and tended to have the opposite
characteristics to the High-VAS group. As mentioned earlier,
some of these factors were to be expected due to the nature of MS.
But, it was not anticipated which (if any) of the EQ-5D dimensions
would be most predictive of a high or a low health state. The
comparison of the health profiles showed that being able to engage
in Usual Activities was most predictive of being in the High-VAS
group, whereas problems with Mobility were most predictive of a
low health state (Low-VAS). Though all the dimensions were
predictive of health state, a tabulation of the odds ratios (Table 3)
showed that Anxiety/depression and Pain/discomfort were among
the least predictive dimensions of being in either the High-VAS or
Low-VAS group. There may be a variety of reasons for this: for
example, it may be that problems in these dimensions can be
managed by therapy and medication. In contrast, not being able to
enjoy their Usual Activities (High-VAS group) and difficulties with
Mobility (Low-VAS group) may be associated with irreversible
deterioration in physical functions, and with loss of social contact
and participation in general life activities. Even so, this does not
detract from the considerable impact of pain and mental health
issues on the lives of people with MS. High scores on all the
dimensions were highly predictive of a low health status, and
conversely, low scores were highly predictive of a high health
status. The magnitude of these effects should be considered
clinically relevant when caring for people with MS and seeking to
promote their quality of life.
What this Study Adds
This is the largest known study of health-related quality of life
via the EQ-5D in people with MS that has been reported to date.
It has shown the high prevalence of problems in all 5 dimensions
of the health profile, and how they vary when different factors are
taken into consideration. It has compared the health states of
people with MS with those of the general UK population, and
found them to be considerably lower, such that the mean health
state for the general population is 1SD above the cohort mean.
Having access to a large cohort has allowed robust sub-group
analyses that would not have been possible with smaller sample
groups. This included being able to divide the cohort into High-
VAS and Low-VAS groups to assess the role of various factors in
predicting a high or low health state. Other examples were being
able to examine the influence of factors, such as educational status,
or living arrangements, on quality of life for people with different
types of MS. This study provides new insights into the patterns of
factors that make up quality of life in people with MS and these
highly significant findings should be considered clinically relevant
to guide the provision of the best care for people with MS and to
inform further research.
Limitations
This study was conducted via the web portal of the UK MS
Register and the respondents were self-selected, and so it is
possible that the data may not be fully representative of the
prevalent MS population. Self-selection may result in response bias
and the use of web-based data collection methods may pose a
barrier to some groups of people, such as the elderly, socially
disadvantaged or the technically inexperienced [22,23]. However,
Table 3. Odds ratios for high and low health states.
Dimension High-VAS Low-VAS
Some problems: severe
problems
No problems: severe
problems
Some problems: no
problems
Severe problems: no
problems
Mobility 10.50 [8.77, 12.5] 23.80 [8.77, 66.67] 5.41 [3.9,7.46] 43.48 [27.03, 71.43]
Self-care 7.57 [4.10, 13.89] 10.99 [8.33, 14.49] 4.27 [3.52, 5.18] 13.70 [10.10, 18.52]
Usual activities 13.33 [10.98, 15.87] 41.67 [25.64, 66.67] 4.29 [2.87, 6.45] 22.22 [14.49, 33.33]
Pain/discomfort 5.99 [5.05, 7.14] 22.22 [13.89, 37.03] 2.44 [1.87, 3.18] 7.87 [5.88, 10.64]
Anxiety/depression 5.00 [4.15, 5.99] 11.49 [6.06, 21.73] 2.47 [2.03, 3.00] 8.77 [6.62, 11.63]
The odds ratios [and confidence intervals] of being in the High-VAS group or the Low-VAS group based on the level of problems reported on the 5 dimensions are
shown.
doi:10.1371/journal.pone.0065640.t003
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the value of remote data collection methods is increasingly being
recognised in epidemiologic studies, with the evidence largely
supporting comparability between web and mail as media for
questionnaire delivery [24]. The educational attainment profile of
our cohort is similar to that of the general UK population, as are
many of the MS-specific characteristics, except that our propor-
tion of people with SPMS is a little lower than expected [5]. This
may be because of poorer health among people with SPMS or
because of diagnosis changes, as people with SPMS would have
firstly been diagnosed with RRMS, and they may be reporting
their earlier diagnosis [4,25]. We will be able to assess any bias in
the portal data using data linkage as the clinical and routine data
accrue. To do this we will anonymously-link the portal data,
clinical and routine data and compare demographic factors (such
as age and gender) and MS-specific factors (such as type and
duration of MS) across the datasets. We will use a population
administrative register as the gold standard for the demographic
variables, and the clinical caseload as the gold standard for the
MS-specific variables. We will then be able to quantify bias in the
portal data and propose correction factors (where relevant) to be
used in generalising findings to the MS population in general. The
UK MS Register is still in its early stages, and although many
studies will be made possible as the data increase over time, others
will still require more traditional settings and data collection
methods [26].
Future Work
A programme of further work is underway to analyse additional
questionnaires delivered via the portal. This will include studying
quality of life (via the EQ-5D), mental health (via the HADS) and
the physical and psychological impact of MS (via the MSIS-29) in
relation to self-reported symptoms and medication reports.
Through the increasing numbers of participants on the portal,
and their periodic return to repeat the questionnaires, we will be
able to explore additional methodologies and to carry out
longitudinal studies. We plan to build upon our qualitative
research and extend our engagement with people with MS, and
other stakeholders, to ensure that the Register meets their needs
and expectations [27–29]. As the data accrue we will be able to
link clinical, routine and portal datasets to compare the
information provided and to carry out additional studies, only
possible via individual-level data linkage. This will include
comparing the Expanded Disability Status Scale (EDSS) scores
from clinical data with self-assessed outcome measures received via
the portal, and factoring in self-reported symptoms, such as
fatigue, which are known to be important to people with MS, but
not captured directly by the EDSS or EQ-5D [30].
Conclusion
The importance of quality of life cannot be over-estimated, and
the EQ-5D is a standardised, health-related quality of life measure
that is widely used to assess general populations and condition-
specific cohorts [12,13]. This large-scale study, with over 4500
participants, has used the EQ-5D to show how people with MS
rate their health-related quality of life, and the factors that impact
upon their health status. The findings can be used to inform care
provision and further research to work towards enhancing the
quality of life of people with MS.
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